financetom
Business
financetom
/
Business
/
Airbnb forecasts quarterly revenue above estimates; plans $6 billion share buyback
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Airbnb forecasts quarterly revenue above estimates; plans $6 billion share buyback
Aug 6, 2025 1:19 PM

Aug 6 (Reuters) - Vacation rentals company Airbnb ( ABNB )

forecast third-quarter revenue above Wall Street

estimates on Wednesday and announced a new share repurchase

program worth $6 billion.

Growth of nights booked in the U.S. accelerated each month

throughout the quarter ended June, driven by domestic travel,

San Francisco-based Airbnb ( ABNB ) said, adding that it was encouraged

by the trend for the current quarter.

Several travel firms, like United Airlines and

Wyndham Hotels, saw a recovery in U.S. travel demand

after a slowdown in April, when consumers initially pulled back

spending due to President Donald Trump's shifting trade policy.

Airbnb's ( ABNB ) average daily rates, or the average cost per night,

in North America rose 3% in the quarter, driven by strong demand

for higher-priced listings.

This trend is consistent with other travel companies,

including hotel operator Marriott ( MAR ), where bookings for

upscale properties and premium offerings helped offset weak

demand in the budget segment.

Excluding the impact of foreign exchange, ADR in Q2 2025

increased 1% and was up across all regions, largely due to price

appreciation, the company said.

Nights and seats booked, an updated metric which includes

the number of services booked, on Airbnb's ( ABNB ) platform rose 7% in

the second quarter, while gross booking value increased 11% to

$23.5 billion.

Airbnb ( ABNB ) expects third quarter revenue between $4.02 billion

to $4.10 billion, the midpoint of which is higher than higher

than analysts' average estimate of $4.05 billion, according to

data compiled by LSEG.

However, the company cautioned that despite stronger night

bookings in North America, growth could moderate given tougher

year-over-year comparisons in the third and fourth quarters.

It expects the implied take rate, or the ratio of revenue to

gross bookings, to remain flat in the third quarter.

The travel company posted a per-share profit of $1.03

compared to 86 cents in the same period last year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca
Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca
May 6, 2024
04:22 AM EDT, 05/06/2024 (MT Newswires) -- Cellectis ( CLLS ) said Monday that AstraZeneca ( AZN ) has completed an additional equity investment of $140 million in the company, after clearance from the French Ministry of Economy. AstraZeneca ( AZN ) has subscribed for 10 million class A convertible preferred shares and 18 million class B convertible preferred shares...
Japanese Yen Underperforms as Australian Dollar Leads G10 FX Higher
Japanese Yen Underperforms as Australian Dollar Leads G10 FX Higher
May 6, 2024
04:36 AM EDT, 05/06/2024 (MT Newswires) -- The Japanese yen fell against all major currencies in early European trade on Monday while the Australian dollar outperformed following a robust performance from risk assets in the Asian trading session. USD/JPY was the biggest mover among major currency pairs, rising 0.58% in Asia to be quoted around 153.72 following the European open....
Lantern Pharma, Oregon Therapeutics Partner to Develop AI-Driven Cancer Drug Collaboration
Lantern Pharma, Oregon Therapeutics Partner to Develop AI-Driven Cancer Drug Collaboration
May 6, 2024
04:37 AM EDT, 05/06/2024 (MT Newswires) -- Lantern Pharma ( LTRN ) and Oregon Therapeutics are partnering to develop drug candidate XCE853 as a cancer treatment, the companies said Monday. Under the terms of the agreement, Lantern Pharma ( LTRN ) will receive equal intellectual property ownership and drug development rights in any newly discovered research findings or treatment strategies...
French carmakers target fourfold jump in EV sales by 2027
French carmakers target fourfold jump in EV sales by 2027
May 6, 2024
PARIS (Reuters) - France's car industry will aim to ramp up electric car sales fourfold by 2027 under a strategy agreement to be signed with the government on Monday, just as the president of China embarks on a state visit in the country. French President Emmanuel Macron has set a goal for the nation's carmakers to produce two million electric or...
Copyright 2023-2026 - www.financetom.com All Rights Reserved